Overview

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.
Phase:
N/A
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Glycerol
Lubricant Eye Drops